A recent article by a team of international experts on multiple sclerosis (MS) underscores the importance of expanding the knowledge base about the hippocampus in order to better understand the genesis of cognitive deficits ...
Oct 16, 2018
0
0
For years, the news about Alzheimer's and other dementia-related illness has been unrelentingly grim. We don't know many of the causes. We don't have a cure.
Jul 23, 2013
0
0
Using a specialised ambulance or mobile stroke unit (MSU) to assess and treat patients who have had a suspected stroke at the site of the emergency roughly halves the time from the initial call for help to treatment decision, ...
Apr 10, 2012
0
0
The first large non-commercial clinical study to investigate whether the main active constituent of cannabis (tetrahydrocannabinol or THC) is effective in slowing the course of progressive multiple sclerosis (MS), shows that ...
Jul 23, 2013
5
0
The sizeable and increasing proportion of women with advanced breast cancer whose disease has spread to the brain could be effectively treated systemically with a combination of two drugs, sparing them the debilitating neurological ...
Nov 1, 2012
0
0
Scientists have discovered that a commonly prescribed dementia drug could hold the key to helping prevent debilitating falls for people with Parkinson's.
Jan 13, 2016
1
11
A paper published this month in the prestigious medical journal The Lancet Neurology suggests that a broad spectrum of developmental and psychiatric disorders, ranging from autism and intellectual disability to schizophrenia, ...
Apr 5, 2013
0
0
Physician-researchers at Indiana University School of Medicine have reported the first effective therapy for a class of previously untreatable and potentially life-threatening tumors often found in children.
Nov 1, 2012
0
0
New research published Online First in The Lancet Neurology indicates that giving the clot-busting drug alteplase up to 6 hours after a stroke reduces long-term disability, significantly increases the likelihood of independence, ...
Jun 20, 2013
0
0
The initial clinical trial of a novel approach to treating amyotrophic lateral sclerosis (ALS) – blocking production of a mutant protein that causes an inherited form of the progressive neurodegererative disease – may ...
Apr 3, 2013
0
0
